Position in PRGO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,061,269
+$5,335,987 QoQ
Shares Held
1,257,100
+74.8% QoQ
Ownership
0.906%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#30
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Derivatives in PRGO
reported options exposure · as of Jun 30, 2026CallValue
$519,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CastleKnight Management LP holds $43,680,979 across 4 Drug Manufacturers - Specialty & Generic names. PRGO ranks #2 (29.9% of the industry book) .
All Filings in PRGO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,061,269 | 1,257,100 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $519,500 | 50,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $1,074,000 | 100,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $7,725,282 | 719,300 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||